Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 6/2016

19.02.2016 | Miscellaneous

Diagnostic and prognostic value of procalcitonin levels in patients with Bell’s palsy

verfasst von: Saffet Kilicaslan, Sinan Uluyol, Mehmet Hafit Gur, Ilker Burak Arslan, Ozlem Yagiz

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Inflammation is thought to play an important role in the pathogenesis of Bell’s palsy (BP). Procalcitonin (PCT) is currently among the most frequently used proinflammatory biomarkers in clinical practice. In this study, we assessed the serum PCT levels for predicting the severity and prognosis of BP. In total, 32 patients with House–Brackmann (HB) grade II and III BP (low-grade group), 22 patients with HB grade IV and V (high-grade group) and 35 healthy individuals (control group) were included in this prospective study. PCT levels were compared among these three groups at the time of diagnosis. All patients received standard prednisolone and acyclovir treatment. The correlation between PCT levels and recovery was analyzed 3 months after treatment. The PCT levels for control, low-grade and high-grade BP groups were 0.01 ± 0.001, 0.35 ± 0.05, and 0.98 ± 0.41 ng/mL, respectively. The PCT level in low-grade group was significantly higher than that in control group (p < 0.001), and the PCT level in high-grade BP group was significantly higher than that in low-grade group (p = 0.01, p < 0.05). The complete recovery rate was 93.7 % in low-grade and 54.5 % in high-grade BP group (p = 0.015, p < 0.05). There was a strong negative correlation between PCT levels and recovery rates (r = −0.896, p < 0.001). PCT levels were significantly associated with the severity of BP and higher PCT levels were related with poor clinical outcome in terms of recovery. These results support the diagnostic and prognostic significance of PCT in patients with early BP.
Literatur
1.
Zurück zum Zitat Baugh RF, Basura GJ, Ishii LE, Schwartz SR, Drumheller CM, Burkholder R et al (2013) Clinical practice guideline: Bell’s palsy. Otolaryngol Head Neck Surg 149(3 Suppl):S1–S27CrossRefPubMed Baugh RF, Basura GJ, Ishii LE, Schwartz SR, Drumheller CM, Burkholder R et al (2013) Clinical practice guideline: Bell’s palsy. Otolaryngol Head Neck Surg 149(3 Suppl):S1–S27CrossRefPubMed
2.
Zurück zum Zitat Peitersen E (2002) Bell’s palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl 549:4–30CrossRefPubMed Peitersen E (2002) Bell’s palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl 549:4–30CrossRefPubMed
4.
Zurück zum Zitat House JW, Backmann DE (1985) Facial nerve grading system. Otolaryngol Head Neck Surg 93:146–147PubMed House JW, Backmann DE (1985) Facial nerve grading system. Otolaryngol Head Neck Surg 93:146–147PubMed
5.
Zurück zum Zitat Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341(8844):515–518CrossRefPubMed Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341(8844):515–518CrossRefPubMed
6.
Zurück zum Zitat Whicher J, Bienvenu J, Monneret G (2001) Procalcitonin as an acute phase marker. Ann Clin Biochem 38(Pt 5):483–493CrossRefPubMed Whicher J, Bienvenu J, Monneret G (2001) Procalcitonin as an acute phase marker. Ann Clin Biochem 38(Pt 5):483–493CrossRefPubMed
7.
Zurück zum Zitat Reinhart K, Karzai W, Meisner M (2000) Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med 26:1193–1200CrossRefPubMed Reinhart K, Karzai W, Meisner M (2000) Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med 26:1193–1200CrossRefPubMed
8.
Zurück zum Zitat Lee WS, Kang DW, Back JH, Kim HL, Chung JH, Shin BC (2015) Cutoff value of serum procalcitonin as a diagnostic biomarker of infection in end-stage renal disease patients. Korean J Intern Med 30:198–204CrossRefPubMedPubMedCentral Lee WS, Kang DW, Back JH, Kim HL, Chung JH, Shin BC (2015) Cutoff value of serum procalcitonin as a diagnostic biomarker of infection in end-stage renal disease patients. Korean J Intern Med 30:198–204CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat van Leeuwen HJ, Voorbij HA (2002) Procalcitonin concentrations in the diagnosis of acute inflammatory reactions. Ned Tijdschr Geneeskd 146:55–59PubMed van Leeuwen HJ, Voorbij HA (2002) Procalcitonin concentrations in the diagnosis of acute inflammatory reactions. Ned Tijdschr Geneeskd 146:55–59PubMed
10.
Zurück zum Zitat Mitaka C (2005) Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. Clin Chim Acta 351:17–29CrossRefPubMed Mitaka C (2005) Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. Clin Chim Acta 351:17–29CrossRefPubMed
11.
Zurück zum Zitat Limper M, de Kruif MD, Duits AJ, Brandjes DP, van Gorp EC (2010) The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J Infect 60:409–416CrossRefPubMed Limper M, de Kruif MD, Duits AJ, Brandjes DP, van Gorp EC (2010) The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J Infect 60:409–416CrossRefPubMed
12.
Zurück zum Zitat Adib-Conquy M, Monchi M, Goulenok C, Laurent I, Thuong M, Cavaillon JM, Adrie C (2007) Increased plasma levels of soluble triggering receptor expressed on myeloid cells 1 and procalcitonin after cardiac surgery and cardiac arrest without infection. Shock 28:406–410CrossRefPubMed Adib-Conquy M, Monchi M, Goulenok C, Laurent I, Thuong M, Cavaillon JM, Adrie C (2007) Increased plasma levels of soluble triggering receptor expressed on myeloid cells 1 and procalcitonin after cardiac surgery and cardiac arrest without infection. Shock 28:406–410CrossRefPubMed
13.
Zurück zum Zitat Jonsson L, Larsson A, Thomander L (1987) Immune complexes and complement components in Bell’s palsy. ORL J Otorhinolaryngol Relat Spec 49:294–301CrossRefPubMed Jonsson L, Larsson A, Thomander L (1987) Immune complexes and complement components in Bell’s palsy. ORL J Otorhinolaryngol Relat Spec 49:294–301CrossRefPubMed
14.
Zurück zum Zitat Larsson C, Bernström-Lundberg C, Edström S, Bergström T (1998) Tumor necrosis factor-alpha response and herpesvirus infection in Bell’s palsy. Laryngoscope 108(8 Pt 1):1171–1176CrossRefPubMed Larsson C, Bernström-Lundberg C, Edström S, Bergström T (1998) Tumor necrosis factor-alpha response and herpesvirus infection in Bell’s palsy. Laryngoscope 108(8 Pt 1):1171–1176CrossRefPubMed
15.
Zurück zum Zitat Yilmaz M, Tarakcioglu M, Bayazit N, Bayazit YA, Namiduru M, Kanlikama M (2002) Serum cytokine levels in Bell’s palsy. J Neurol Sci 197:69–72CrossRefPubMed Yilmaz M, Tarakcioglu M, Bayazit N, Bayazit YA, Namiduru M, Kanlikama M (2002) Serum cytokine levels in Bell’s palsy. J Neurol Sci 197:69–72CrossRefPubMed
16.
Zurück zum Zitat Bucak A, Ulu S, Oruc S, Yucedag F, Tekin MS, Karakaya F, Aycicek A (2014) Neutrophil-to-lymphocyte ratio as a novel-potential marker for predicting prognosis of Bell palsy. Laryngoscope 124:1678–1681CrossRefPubMed Bucak A, Ulu S, Oruc S, Yucedag F, Tekin MS, Karakaya F, Aycicek A (2014) Neutrophil-to-lymphocyte ratio as a novel-potential marker for predicting prognosis of Bell palsy. Laryngoscope 124:1678–1681CrossRefPubMed
17.
Zurück zum Zitat Kum RO, Yurtsever Kum N, Ozcan M, Yilmaz YF, Gungor V, Unal A, Ciliz DS (2015) Elevated neutrophil-to-lymphocyte ratio in Bell’s palsy and its correlation with facial nerve enhancement on MRI. Otolaryngol Head Neck Surg 152:130–135CrossRefPubMed Kum RO, Yurtsever Kum N, Ozcan M, Yilmaz YF, Gungor V, Unal A, Ciliz DS (2015) Elevated neutrophil-to-lymphocyte ratio in Bell’s palsy and its correlation with facial nerve enhancement on MRI. Otolaryngol Head Neck Surg 152:130–135CrossRefPubMed
18.
Zurück zum Zitat Atan D, Ikinciogullari A, Koseoglu S, Ozcan KM, Cetin MA, Ensari S, Dere H (2015) New predictive parameters of Bell’s palsy: neutrophil to lymphocyte ratio and platelet to lymphocyte ratio. Balkan Med J 32:167–170CrossRefPubMedPubMedCentral Atan D, Ikinciogullari A, Koseoglu S, Ozcan KM, Cetin MA, Ensari S, Dere H (2015) New predictive parameters of Bell’s palsy: neutrophil to lymphocyte ratio and platelet to lymphocyte ratio. Balkan Med J 32:167–170CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Sullivan FM, Swan IR, Donnan PT et al (2009) A randomised controlled trial of the use of aciclovir and/or prednisolone for the early treatment of Bell’s palsy: the BELLS study. Health Technol Assess 13:iii–iv, ix–xi 1–130 Sullivan FM, Swan IR, Donnan PT et al (2009) A randomised controlled trial of the use of aciclovir and/or prednisolone for the early treatment of Bell’s palsy: the BELLS study. Health Technol Assess 13:iii–iv, ix–xi 1–130
21.
Zurück zum Zitat Sullivan FM, Swan IR, Donnan PT, Morrison JM, Smith BH, McKinstry B et al (2007) Early treatment with prednisolone or acyclovir in Bell’s palsy. N Engl J Med 357:1598–1607CrossRefPubMed Sullivan FM, Swan IR, Donnan PT, Morrison JM, Smith BH, McKinstry B et al (2007) Early treatment with prednisolone or acyclovir in Bell’s palsy. N Engl J Med 357:1598–1607CrossRefPubMed
Metadaten
Titel
Diagnostic and prognostic value of procalcitonin levels in patients with Bell’s palsy
verfasst von
Saffet Kilicaslan
Sinan Uluyol
Mehmet Hafit Gur
Ilker Burak Arslan
Ozlem Yagiz
Publikationsdatum
19.02.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 6/2016
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-016-3937-1

Weitere Artikel der Ausgabe 6/2016

European Archives of Oto-Rhino-Laryngology 6/2016 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.